🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ivana Gojo

Johns Hopkins University

ORCID: 0000-0003-0312-3412

Also affiliated with Sidney Kimmel Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML”.

TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

Blood Advances(2020)10.1182/bloodadvances.2020002512

N/A

3.8DataRank · unranked

155 citations

Catherine Lai, Stephen Reeder, S. Church, Tressa Hood, Anbarasu Lourdusamy +24 more

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Blood Advances(2020)10.1182/bloodadvances.2020001648

N/A

3.1DataRank · unranked

74 citations

Marianna Zahurak, Yilin Cao, Allen Chen, Kenneth R. Cooke, Christopher Gamper +16 more

Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia

Journal of Clinical Investigation(2022)10.1172/jci159579

N/A

2.3DataRank · unranked

94 citations

Jayakumar Vadakekolathu, Francesco Mazziotta, Stephen Reeder, Tung On Yau, Rupkatha Mukhopadhyay +16 more

Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity

Nature Cancer(2024)10.1038/s43018-024-00736-x

N/A

0.524DataRank · unranked

32 citations

Xin He, Lei Zhang, Wei Chen, Yi‐Chun Lin, Songbai Liu +27 more

Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide

Blood Advances(2020)10.1182/bloodadvances.2020002945

N/A

0DataRank · unranked

31 citations

Leo Luznik, Hua-Ling Tsai, Philip Imus, Amy E. DeZern, Keith W. Pratz +21 more

Treatment of AML Relapse After Allo-HCT

Frontiers in Oncology(2021)10.3389/fonc.2021.812207

N/A

0DataRank · unranked

36 citations

Leo Luznik, Ivana Gojo, Jonathan Webster

Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia

Journal of Oncology Pharmacy Practice(2021)10.1177/10781552211024727

N/A

0DataRank · unranked

12 citations

Bryan C. Hambley, Erin Hickey, Sarah Kashanian, Andrew Li, Maria R. Baer +11 more

Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience

Clinical Lymphoma Myeloma & Leukemia(2021)10.1016/j.clml.2021.09.022

N/A

0DataRank · unranked

6 citations

Matthew L. Smith, Hua‐Ling Tsai, Ravi Varadhan, Amy E. DeZern, W. Brian Dalton +23 more

Immune escape and immunotherapy of acute myeloid leukemia

Journal of Clinical Investigation(2020)10.1172/jci129204

N/A

0DataRank · unranked

342 citations

Ivana Gojo, Luca Vago

Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.02.004

N/A

0DataRank · unranked

27 citations

Hua‐Ling Tsai, Amy E. DeZern, Lukasz P. Gondek, Hany Elmariah, Javier Bolaños‐Meade +22 more

Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.12.018

N/A

0DataRank · unranked

7 citations

Madison Reed, Hua‐Ling Tsai, Alexander J. Ambinder, Tania Jain, Amy E. DeZern +25 more

Signatures of immune senescence predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia

medRxiv(2022)10.1101/2022.02.08.22270578

N/A

0DataRank · unranked

3 citations

Jayakumar Vadakekolathu, Francesco Mazziotta, Stephen Reeder, Tung On Yau, Rupkatha Mukhopadhyay +14 more

Data from Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias

(2023)10.1158/1078-0432.c.6517540.v1

N/A

0DataRank · unranked

0 citations

Takeo Nakanishi, Ming Tan, Hong‐Bin Fang, Wen-chyi Wang, Martin J. Edelman +5 more

Data from Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias

(2023)10.1158/1078-0432.c.6517540

N/A

0DataRank · unranked

0 citations

Takeo Nakanishi, Ming Tan, Hong‐Bin Fang, Wen-chyi Wang, Martin J. Edelman +5 more

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing

Blood Advances(2020)10.1182/bloodadvances.2019001127

N/A

0DataRank · unranked

60 citations

Eric Helmenstine, Lisa Pieterse, Bing Li, Christopher D. Gocke, Joshua Donaldson +8 more

Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities

Leukemia Research(2025)10.1016/j.leukres.2025.108098

N/A

0DataRank · unranked

1 citations

Daniel Li, Hua‐Ling Tsai, Gabriel Ghiaur, B. Douglas Smith, Mark J. Levis +10 more